CYSTEINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cysteine, and when can generic versions of Cysteine launch?
Cysteine is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in CYSTEINE is cysteine hydrochloride. There are fourteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the cysteine hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CYSTEINE?
- What are the global sales for CYSTEINE?
- What is Average Wholesale Price for CYSTEINE?
Summary for CYSTEINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | CYSTEINE at DailyMed |
US Patents and Regulatory Information for CYSTEINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | CYSTEINE HYDROCHLORIDE | cysteine hydrochloride | INJECTABLE;INJECTION | 019523-001 | Oct 22, 1986 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |

